vimarsana.com

Vulnerable Plaque News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Elixir Medical To Present Randomized Clinical Dataset Featuring World s First Triple Drug-Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus at TCT 2023

Primary endpoint, six-month clinical and imaging data from clinical trial of DESyne BDS Plus stent system evaluating safety and efficacy of localized delivery of anticoagulants and an anti-proliferative agent designed to reduce the implant thrombotic risk

New zealandSan franciscoUnited statesRoxana mehranStefan verheyeRobertw yehMotasim sirhanMirvat alasnagMark websterIgnacio cruz gonzalezDavid erlingeDynamx hong kongClinical science researchClinical science research sessionsMoscone centerInnovation program

SHL Telemedicine s SmartHeart® Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London Trials

Promising outcomes indicate significant reductions in emergency visits and hospital readmissions, alongside reductions in healthcare utilization costs relating to post-MI patient treatment .

City ofUnited kingdomErez nachtomyNasdaq stock exchangeTelemedicine ltdSwiss exchangeImperial college londonMayo clinicVulnerable plaquePatient meeting

SHL Telemedicine : Mayo Clinic study initial results -September 26, 2023 at 03:43 am EDT

Press release SHL Telemedicine s SmartHeart® technology shows remarkable effects in Mayo Clinic and Imperial College London trials .

City ofUnited kingdomErez nachtomyTelemedicine ltdImperial college londonMayo clinicNew yorkVulnerable plaquePatient meeting

SHL Telemedicine Ltd : SHL Telemedicine s SmartHeart Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London Trials

SHL Telemedicine Ltd : SHL Telemedicine s SmartHeart Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London Trials
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomBaden wübergErez nachtomyFabienne farnerTelemedicine ltdImperial college londonNasdaq stock exchangeSwiss exchangeMayo clinicVulnerable plaquePatient meetingLooking statements

SHL Telemedicine s SmartHeart® Technology to Take Center Stage at Upcoming VPM 2023 Conference

TEL AVIV, Israel & ZURICH & NEW YORK, September 11, 2023 SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that initial results from trials conducted by the Mayo Clinic (as part of a previously announced collaboration) and by Imperial College London will be featured in two upcoming presentations at the Imperial Vulnerable Plaque and Patient Meeting 2023 (VPM). Both tria

City ofUnited kingdomErez nachtomyNaseer alshahraniJoerg hermannRamzi khamisSwiss exchangeNasdaq stock exchangeImperial college londonAcute coronary syndromeMayo clinicMajor adverse cardiovascular eventsVulnerable plaquePatient meetingHeart attackMayo clinic

vimarsana © 2020. All Rights Reserved.